The jury

The judges consists of:

 

RietjeMrs. Prof. Dr. R. van Dam-Mieras, Dutch National Committee for UNESCO (President of the Jury) 

Rietje van Dam-Mieras is emeritus professor Sustainable Development and Innovation of Education at Leiden University. She served as a member of the Executive Board of Leiden University between 2007 and 2011. Before that, she worked at Utrecht University, Maastricht University and the Open University of the Netherlands. At the Open University she was professor of Natural Sciences (particularly Biochemistry and Biotechnology).

Rietje Van Dam-Mieras is currently, amongst others, member of the National UNESCO Commission, board member of the Knowledge and Innovation Top Consortium for the Biobased Economy and member of the Deltares Advisory Committee.

 

paul emmelkampMr. Prof. dr. P.M.G. Emmelkamp, Professor of clinical psychology at the University of Amsterdam and Rector of the NIAS

Paul Emmelkamp is a licensed psychotherapist and clinical psychologist and was appointed in 1996 as full professor of clinical psychology at the University of Amsterdam. He attended Utrecht University where he received his PhD in 1975. Before moving to Amsterdam he held positions at the University of Groningen, where he was appointed as full professor in Clinical Psychology in 1986. Paul Emmelkamp has contributed to a number of areas in clinical psychology, psychopathology and psychiatry. He has written and co-edited many books on research into a variety of clinical subjects. He is Co-Editor in Chief of Clinical Psychology & Psychotherapy, and serves on the editorial board of a number of journals in psychology and psychiatry, including Journal of Anxiety Disorders and Psychotherapy & Psychosomatics.

Paul Emmelkamp has received a number of honours and awards, including membership of the Royal Academy of Arts and Sciences (KNAW), an honorary membership of the Dutch Association of Behaviour and Cognitive Therapy, and the Senior Heijmans award for his lifetime achievements from the Dutch Institute of Psychologists (NIP). In 2006 he was awarded a distinguished professorship (‘academy professor’) by the Royal Academy of Arts and Sciences (KNAW). In 2014 he received the award of the European Association of Behaviour and Cognitive Therapy. Since 2014 he is Rector of the Netherlands Institute for Advanced Study.

Over the years Emmelkamp has published therapy-outcome studies on adults with work-related distress, substance abuse disorders, personality disorders, depression, and anxiety disorders and on children and adolescents with ADHD, conduct disorder and anxiety disorders. His most recent contributions concern the application of information technology to the treatment of patients. Apart from his involvement in the evaluation of psychotherapy through the Internet, a major contribution in this domain consists of the development and evaluation of controlled clinical trials on virtual reality exposure therapy for anxiety disorders. Other research interests include forensic psychiatry, intimate partner violence, and experimental psychopathology.

Foto Marie Jose Goumans

Mrs. Prof. Dr. M.J. Goumans, Professor of molecular cardiovascular cell biology at the University of Leiden

While studying biology at the University of Utrecht, Marie-José became enthusiastic about the fields of cardiovascular development and stem cell biology. After graduating, she continued her research investigating the role of TGFbeta in cardiovascular development at the Hubrecht Laboratory under the supervision of Christine Mummery, and received her PhD in 1999 with a thesis entitled: Functional analysis of TGFbeta signalling in early mouse development.

In 2003 she moved to the department of cardiology at the UMC in Utrecht, where she became an assistant professor and initiated studies on cardiac progenitor cells. She was awarded a VIDI grant from NWO to study the role of cardiac progenitor cells in myocardial regeneration. In 2008, Dr Goumans became an Associate Professor at the Dept of Molecular Cell Biology at the Leiden UMC. In 2009, she became a member of the YoungAcademy of the KNAW, the RoyalDutchAcademy of Science, and has been vice president since 2011. In February 2012, Marie Goumans was appointed as Prof. of molecular cardiovascular cell biology at the LUMC. Her current research interests include cardiac commitment and differentiation of cardiac progenitor cells as well as TGFβ signalling in cardiovascular development and disease.

ana leeMrs. A. Lee, Senior Scientific and Regulatory Affairs Specialist L’Oréal Benelux

Ana Lee holds a master’s degree in Bio-Pharmaceutical Sciences with a Science Based Business specialization from Leiden University. She is currently responsible for the Scientific and Regulatory affairs department of L’Oréal Netherlands. Within this position she ensures among others the compliance of the Group’s wide range of products with relevant regulations and oversees the post-marketing surveillance. She represents L’Oréal at the Dutch Cosmetics Association (NCV) in the technical committee, which deals with all matters concerning legislation with regard to the safety of the products and developments relating to cosmetic ingredients.

Foto: Bram Saeys. Afscheidsreceptie Wim van Saarloos FOM Differ TU/e, 16-6-2015
Foto: Bram Saeys.

Dr. Ir. Wim van Saarloos, program director TransitionNWO

Completing his studies of Thoretical Physics and graduating in Leiden in 1982, Wim Saarloos worked at Bell Laboratories in the USA for a period of over 8 years. In 1991 he returned as a professor at the university of Leiden where he started a research group in the field of unbalanced forces in physics, for example: spontaneous pattern formation, front propagation and granular media. He was co-founder of the Lorentz Center, a workshop center where he worked as a director until 2009. In November 2009 Wim van Saarloos took the position of director at the FOM Foundation until in 2015 he was asked to lead the transition of the NWO, forming a new organisation model that combined four domains under one institutional organisation. On the 1st of January 2017 he will be returning to the University of Leiden as a professor of Theoretical Physics. On September 1st 2016 Wim van Saarloos was appointed vice-president of the KNAW from which he will be promoted to president of the KNAW in 2018. Wim van Saarloos received the Elisabeth Parvé Steyn Prize in 2012 for his accomplishments for women in science.

 

 

 

Annelien

Mrs. Dr. A.L. Bredenoord, Professor Ethics of Biomedical Innovation at UMC (Universitair Medisch Centrum Utrecht) and member of the first chamber of the State’s General (Eerste Kamer der Staten-Generaal) on behalf of D66.

Annelien Bredenoord is professor Ethics of Biomedical Innovation at UMC in Utrecht. She studied Theology and Political Science at the University of Leiden and completed her graduation at the medical faculty of the University of Maastricht in 2010. She concentrated on ethical and social issues concerning new biomedical technology such as genetics, stem cell research, biobanks and reproductive medicine. She guides and helps other graduates and students and has received a VENI grant for her ethics on stem cell research. Her current projects are being financed by ZonMw and KWF, to name a few.

She serves on the boards of multiple (inter) national committees such as the Ethics Committee of the International Society for Stem Cell Research, the Scientific Board of the European Meeting on Psycho-Social Aspects of Genetics, the scientific advice board of the NIAS Lorentz Program, the national Indication commission of Preimplantation Genetic Diagnostics (Preimplantatie Genetische Diagnostiek)  and the METC of UMC Utrecht (the Medische Ethische Toelatingscommissie). She was a member of the Jonge Gezondheidsraad (the Youth Health Commission) from 2011-2013 and has been a member of the KNAW Jonge Akademie (the young Academy) since 2014.

Science and technology are becoming more and more entwined with ethics, politics and modern day society. This is the main reason why Bredenoord always looks for cooperation with other disciplines and political and social organisations. She published more than 50 scientific articles and is a well-known public figure in the media, in her opinion scientific debate should not be limited to academics.

She has been a member of the Eerste Kamer der Staten-Generaal (the First Chamber of the State’s General) on behalf of D66 since June 2016. Her responsibilities include General Health, privacy and family law.

Angela MaasMrs. Dr. Prof. Angela Maas, Professor at the Cardiology department, specializing in female conditions at the Radboud University in Nijmegen.

After graduating as a medical doctor, Angela Maas (born 1956) specialized in Cardiology at the Antonius Hospital in Nieuwegein, where she obtained her registration in 1988.

Following her registration she worked in Arnhem for four years, she then transferred to the  Isala Clinics in Zwolle where she worked from 1992 until 2012. During the past 25 years she studied cardiovascular diseases, focusing on the differences between male and female. She attended multiple international training courses in Canada, USA and Berlin. In 2003 she started cardiologic consolation hours for women and in 2006 she was promoted on this subject at the UMCU. Since May 2012 she works as a Professor at the Cardiology department, specializing in female conditions at the Radboud University in Nijmegen. In 2010 she won the Corrie Hermann Award from the Dutch Association for Feminine Doctors (VNVA) and also obtained the Libelle Award. In 2014 she received the Hemesdorf award from the Radboud University. Currently she is one of the most powerful women in Dutch healthcare (Opzij 2010-2015). She is mostly interested in health problems and innovative research projects for middle-aged women. Accordingly, she gains new insights through consulting different academic disciplines such as gynecology, the vascular intern, cardiac imaging, cardio-oncology and first-line medicine. Within the department cardiology for women, Angela is also responsible for leading the Centre of excellence for Microvascular Coronary Disease (MCD). Apart from her job she is an active member in several committees, to name a few examples: the VNVA, the board of the national network of female professors (LNVH) and the national alliance of Gender & Health. She is also a member of the board of control of Saxenburghgroep in Coevorden/Hardenberg. On a European level, she has an important role in implementing gender sensitive care within the cardiovascular healthcare.